DOCSLIB.ORG

Bugs & Drugs REFERENCES November 2018 GENERAL 1. Anon

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Bugs & Drugs REFERENCES November 2018 GENERAL 1. Anon. Drugs for bacterial infections. Treatment Guidelines Med Lett 2010;8: 43-52. 2. Blondel-Hill E, Nigrin J. Guide to antimicrobial susceptibility testing & reporting. Dynacare Kasper Medical Laboratories/BC Children's Hospital. 2017. 3. Gattis WA. A selected review of antimicrobial concentrations within tissues of the bone, eye, and lung. Antimicrobics Infect Dis Newslett 1994;13:75-86. 4. Gilbert DN, Moellering RC, Eliopoulos GM, eds. The Sanford guide to antimicrobial therapy 2017. Sperryville, VA: Antimicrobial Therapy, Inc. 2017. 5. Gorbach SL, Mensa J, Gatell JM. 1999 pocket book of antimicrobial therapy & prevention. Baltimore, Maryland: Williams & Wilkins1999. 6. Lovgren M, Talbot JA. Antimicrobial-resistant Streptococcus pneumoniae. Can J Infect Dis 1999;10:27-9A. 7. Mandell GL, Bennett JE, and Dolin R, eds. Mandell, Douglas and Bennett’s principles & practice of infectious diseases. 7th ed. New York: Churchill Livingstone Inc. 2009. 8. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 12th ed. 2005-06. 9. Yu VL, Merigan TC, Barriere SL, eds. Antimicrobial therapy and vaccines. Baltimore, Maryland: Williams & Wilkins 1999. ANTIMICROBIAL SPECTRUM OF ACTIVITY 1. Cho JC, Fiorenza MA, Estrada SJ. Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination. Pharmacotherapy 2015;35:701-15. 2. Craig WA, Andes DR. In vivo activities of ceftolozane, a new cepahalosporin, with and without tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, including strains with extended- spectrum β-lactamases, in the thighs of neutropenic mice. Antimicrob Agents Chemother 2013;57:1577-82. 3. Farrell DJ, Flamm RK, Sader HS, et al. Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. hospitals (2011-2012). Antimicrob Agents Chemother 2013;57:6305-10. 4. Gilbert DN, Moellering RC, Eliopoulos GM, eds. The Sanford guide to antimicrobial therapy 2018. Sperryville, VA: Antimicrobial Therapy, Inc. 2018. 5. Grayson ML, Crowe SM, McCarthy JS, et al, eds. Kucers’ the use of antibiotics 6th edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs. 2010 CRC Press, Boca Raton FL. 6. Scott LJ. Ceftolozane/tazobactam: a review in complicated intra- abdominal and urinary tract infections. Drugs 2016;76:231-42. 7. Solomkin J, Hershberger E, Miller B, et al. Ceftolozane/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI). Clin Infect Dis 2015;60:1462-71. 8. Sucher AJ, Chahine EB, Cogan P, et al. Ceftolozane/tazobactam: a new cephalosporin and β-lactamase inhibitor combination. Ann Pharmacother 2015;49:1046-56. 9. Versalovic J, Carroll KC, Funke G, et al. Manual of clinical microbiology, 10th edition, 2011. Washington, DC: ASM Press 2011. 10. Wagenlehner FM, Umeh O, Steenbergen J, et al. Ceftolozane/ tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). Lancet 2015;385:1949-56. 11. Zhanel GG, Chung P, Adam H, et al. Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant Gram-negative bacilli. Drugs 2014;74:31- 51. PHARMACODYNAMICS OF ANTIMICROBIALS 1. Ambrose PG, Bhavnani SM, Rubino CM, et al. Pharmacokinetics- pharmacodynamics of antimicrobial therapy: it’s not just for mice anymore. Clin Infect Dis 2007;44:79-86. 2. Andes D. In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis. Antimicrob Agents Chemother 2003;47:1179-86. 3. Andes D, vanOgtrop ML, Peng J, et al. In vivo pharmacodynamics of a new oxazolidinone (linezolid). Antimicrob Agents Chemother 2002;46:3484-9. 4. Craig WA. Does the dose matter? Clin Infect Dis 2001;33(suppl 3):S233-7. 5. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-12. 6. Crandon JL, Nicolau DP. Pharmacodynamic approaches to optimizing beta-lactam therapy. Crit Care Clin 2011;27:77-93. 7. Gilbert DN, Moellering RC, Eliopoulos GM, eds. The Sanford guide to antimicrobial therapy 2012. Sperryville, VA: Antimicrobial Therapy, Inc. 2012. 8. Michalopoulos AS, Falagas ME. Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann Intensive Care 2011;1:30-5. 9. Roberts JA, Lipman F. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009;37:840-51. 10. Wilby KJ, Nasr ZG, Elazzazy S, et al. A review of clinical outcomes associated with two meropenem dosing strategies. Drugs R D 2017;17:73-8. 11. Wispelway B. Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones. Clin Infect Dis 2005;40(suppl 7):S439-47. EXTENDED INTERVAL AMINOGLYCOSIDE DOSING/MONITORING GUIDELINES 1. Ali MZ, Goetz MB. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997;24:796-809. 2. Ariano RE. A critical evaluation of “once daily” aminoglycoside therapy. Health Sciences Centre Drug Info Bulletin 1993;15(6). 3. Bailey TC, Little JR, Littenberg B, et al. A meta-analysis of extended- interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997;24:786-95. 4. Bates RD, Nahata MC. Once-daily administration of aminoglycosides. Ann Pharmacother 1994;28:757-66. 5. Bertino JS, Rotschafer JC. Editorial response: single daily dosing of aminoglycosides-a concept whose time has not yet come. Clin Infect Dis 1997;24:820-23. 6. Blaser J, Konig C, Simmen HP, et al. Monitoring serum concentrations for once-daily netilmicin dosing regimens. J Antimicrob Chemother 1994;33:341-8. 7. Conly JM, Gold W, Shafran SD. Once-daily aminoglycoside dosing: a new look at an old drug. Can J Infect Dis 1994;5:205-6. 8. Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, et al. Extended- interval aminoglycoside administration for children: a meta-analysis. Pediatrics 2004;114:e111-8. 9. Craig WA. Once-daily dosing of aminoglycosides. Can J Infect Dis 1994;5:28C-33C. 10. Gilbert DN. Editorial response: meta-analyses are no longer required for determining the efficacy of single daily dosing of aminoglycosides. Clin Infect Dis 1997;24:816-19. 11. Gilbert DN. Minireview: once-daily aminoglycoside therapy. Antimicrob Agents Chemother 1991;35:399-405. 12. Hatala R, Dinh T, Cook DJ. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 1996;124:717-25. 13. Hatala R, Dinh TT, Cook DJ. Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review. Clin Infect Dis 1997;24:810-15. 14. Hemsworth S, Nunn AJ, Selwood K, et al. Once-daily netilmicin for neutropenic pyrexia in paediatric oncology. Acta Paediatr 2005;94:268-74. 15. Hitt CM, Klepser ME, Nightingale CH, et al. Pharmacoeconomic impact of once-daily aminoglycoside administration. Pharmacotherapy 1997;17:810-14. 16. Kirkpatrick CMJ, Duffull SB, Begg EJ. Once-daily aminoglycoside therapy: potential ototoxicity. Antimicrob Agents Chemother 1997;41:879-80. 17. Knoderer CA, Everett JA, Buss WF. Clinical issues surrounding once- daily aminoglycoside dosing in children. Pharmacother 2003;23:44- 56. 18. Levison ME. New dosing regimens for aminoglycoside antibiotics. Ann Intern Med 1992;117:693-4. 19. Marra F, Partovi N, Jewesson P. Aminoglycoside administration as a single daily dose: an improvement to current practice or a repeat of previous errors? Drugs 1996;52:344-70. 20. Nicolau DP, Freeman CD, Belliveau PP, et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 1995;39:650-5. 21. Prins JM, Buller HR, Kuijper EJ, et al. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993;341:335-9. 22. Smyth A, Tan KHV, Hyman-Taylor P, et al. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis - the TOPIC study: a randomised controlled trial. Lancet 2005;365:573-8.VandenBussche HL, Klepser MR. Editorial. Lancet 2005;365:547-8. 23. Sung L, Dupuis LL, Bliss B, et al. Randomized controlled trial of once- versus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation. J Natl Cancer Inst 2003;95:1869-77. 24. Tomlinson RJ, Ronghe M, Goodbourne C, et al. Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia. Arch Dis Child 1999;80:125-31. 25. Zaske DE. Aminoglycosides. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics: principles of therapeutic drug monitoring. Vancouver, WA: Therapeutics; 1992;14:1-47. VANCOMYCIN DOSING/MONITORING GUIDELINES 1. Ariano RE, Fine A, Sitar DS, et al. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis. Am J Kid Dis 2005;46:681-7. 2. Bauer LA. Applied Clinical Pharmacokinets. Chapter 5: Vancomycin. McGraw-Hill, 2001. 3. Brown M, Polisetty R, Gracely EJ, et al. Weight based loading of vancomycin in patients on hemodialysis. Clin Infect Dis 2011;53:164- 6. 4. Edwards D, Pancorbo S. Routine monitoring of serum vancomycin concentrations: waiting for proof of its value. Clin Pharm 1987;6:652- 4. 5. Fekety R. Vancomycin and teicoplanin. In: Mandell GL, Bennett JE, Dolin R,
Recommended publications
  • Journal AMERICAN COLLEGE of DENTISTS

    Journal AMERICAN COLLEGE of DENTISTS

    Volume 19 Number 1 Journal AMERICAN COLLEGE OF DENTISTS March 1952 Published Quarterly for General Circulation by THE AMERICAN COLLEGE OF DENTISTS $3.00 a Year 75 Cents a Cony JOURNAL American College of Dentists Presents the proceedings of the American College of Dentists and such additional papers and comment from responsible sources as may be useful for the promotion of oral health- service and the advancement of the dental profession. The Journal disclaims responsibility, however, for opinions expressed by authors. Published Four Times a Year—March, June, September, December Entered as Second Class Matter September 3, 1948 at the Post Office at Baltimore, Maryland under the Act of March 3, 1879 Copyright, 1952, by the American College of Dentists—Made in United States of America THE WAVERLY PRESS, INC., BALTIMORE, MD., U.S.A. Address of the Editor: John E. Gurley, D.D.S. 350 Post Street, San Francisco, 8, Calif. Entered in the Index To Dental Periodic Literature. American College of Dentists Objects: The American College of Dentists "was established to promote the ideals of the dental profession; to advance the standards of efficiency of dentistry; to stimulate graduate study and effort by dentists; to confer Fellowship in recognition of meritorious achievement, especially in dental science, art, education and literature; and to improve public understand- ing and appreciation of oral health-service."—Constitution, Article I. Announcements Next Meeting, Board of Regents: St. Louis, Sept. 5, 1952 Next Convocation: St. Louis, September 7, 1952 Fellowships and awards in dental research. The American College of Dentists, at its annual meeting in 1937 [J.
  • CALENDAR University of Queensland

    CALENDAR University of Queensland

    CALENDAR OF THE University of Queensland FOR THE YEAR 1937 E ditor: T. E. JONES, B.A. The matter contained in this book has been wholly set np and printed in Australia by the Government Printer, Brisbane. Year of Publication, 1937 BRISBANE : By Authority oi the University of Queensland : DAVID WHYTE, Government Printer* Price 3/. The Calendar O F T H E University of Queensland FOR THE YEAR . 1937 . Editor: T. E. JONES. B.A. T h e matter in this book has been wholly set-up and printed by the Government Printer. Brisbane. Year of Publication. 1937 BRISBANE: By Authority of the University of Queensland: D AVID W HYTE, Government Printer- Price 3/. CALENDAR—UNIVERSITY OF QUEENSLAND. TABLE OF CONTENTS. PAGE. Academic Costume 74 Act to Incorporate and Endow the University of Queensland 31 Adult Matriculation 316 Alphabetical Table of Contents 5 Benefactions bestowed by Private Persons 280 Bibliographical Record, 1936 266 Calendar for January, 1937-March, 1938 14 Class Lists, Final Honours Examination, 1936 1 267 Classifying Examinations of Department of Public Instruction 326 Degrees conferred in 1936 268 Details of Subjects— Faculty of Agriculture .. .. .. .. 177 Faculty of Arts 92 Faculty of Commerce 169 Faculty of Dentistry 188 Faculty of Engineering 145 Faculty of Law 196 Faculty of Medicine 201 Faculty of Science 127 Faculty of Veterinary Science 209 External Students 126 General Rules 81 * Graduation in a Second Faculty Lectureships, Medals, Prizes, Scholarships— Archibald Scholarship 245 C.M.A. Award 265 Duncan McNaughton Scholarship 261 Ford Memorial Medal 254 Foundation Scholarships (Government) 239 Free Passages to Europe 244 Freemasons’ Scholarships 262 Gertrude Mary Woolcock Memorial Prize 258 Gold Medals (Government) 240 Hall Fellowship in Economic Biology .
  • JOURNAL of the AMERICAN COLLEGE of DENTISTS Vol

    JOURNAL of the AMERICAN COLLEGE of DENTISTS Vol

    JOURNAL OF THE AMERICAN COLLEGE OF DENTISTS Vol. 9 . DECEMBER, 1942 . No. 4 Contents A Standard Procedure for Determining Abrasion by Dentifrices. Maurice L. Minter, M.D., and Sidney Epstein, D.D.S 353 Concerning the Character of the Age Changes in Enamel and Dentin and Their Relation to the Vital Dental Pulp. Charles F. Bodecker, D.D.S 380 Critical Analysis of Dr. Bodecker's Paper. Wm. J. Gies, Ph.D 390 Dentistry Takes the Initiative. Albert L. Midgley, D.M.D., Sc.D 400 Won't You Walk a Little Faster? Willard C. Fleming, D.D.S 404 American College of Dentists: Proceedings of St. Louis Meeting: Board of Regents and Committee Chairmen, Aug. 27-28, 1942: Reports of Committees: Education. Willard C. Fleming, D.D.S., Chairman 409 Necrology. John V. Conzett, D.D.S., Chairman 412 Preventive Service. L. A. Cadarette, D.D.S., Chairman 416 Report of the Board of Regents. (Including report on Sectional Meetings.) Otto W. Brandhorst, D.D.S., Secretary 418 Meeting of New York and New Jersey Sections: Action Relative to the Journal of Dental Research. Lowrie J. Porter, D.D.S., Secretary, New York Section 433 Journal of Dental Research: William J. Gies Endowment Fund, Report of the Treasurer. Leuman M. Waugh, D.D.S., Treasurer 436 Editorials: Dental Literature, 447; Indium in Dentistry, 448; War, Accidents and the Future, 450; Work But Not for Pay, 452; Foes Within and Foes Without, 453; Journal of Dental Research: William J. Gies Endowment Fund, 453. Erratum 454 Correspondence and Comment: Additional Opinions on the Recent Commercial Exploitation of the Journal of Dental Research 455 Further Comment on "Admiralcy in the Navy Dental Corps" 461 Notes: Dental Research and Commercial Entanglements, 464; Personalities at Dental Meet- ings, 466; Does Yes Mean No?, 467; New Information About the "Harvard Plan", 468; Attendance at U.